Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys.
Adolescent
Adult
Anti-Infective Agents
/ therapeutic use
Canada
/ epidemiology
Child
Cross Infection
/ epidemiology
Drug Resistance, Microbial
Female
Health Surveys
Hospitals
/ statistics & numerical data
Humans
Infant
Infection Control
/ trends
Male
Methicillin-Resistant Staphylococcus aureus
/ pathogenicity
Middle Aged
Population Surveillance
Prevalence
Staphylococcal Infections
/ drug therapy
Journal
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
ISSN: 1488-2329
Titre abrégé: CMAJ
Pays: Canada
ID NLM: 9711805
Informations de publication
Date de publication:
09 Sep 2019
09 Sep 2019
Historique:
accepted:
11
07
2019
entrez:
11
9
2019
pubmed:
11
9
2019
medline:
23
6
2020
Statut:
ppublish
Résumé
Health care-associated infections are a common cause of patient morbidity and mortality. We sought to describe the trends in these infections in acute care hospitals, using data from 3 national point-prevalence surveys. The Canadian Nosocomial Infection Surveillance Program (CNISP) conducted descriptive point-prevalence surveys to assess the burden of health care-associated infections on a single day in February of 2002, 2009 and 2017. Surveyed infections included urinary tract infection, pneumonia, We surveyed 28 of 33 (response rate 84.8%) CNISP hospitals (6747 patients) in 2002, 39 of 55 (response rate 71.0%) hospitals (8902 patients) in 2009 and 47 of 66 (response rate 71.2%) hospitals (9929 patients) in 2017. The prevalence of patients with at least 1 health care-associated infection increased from 9.9% in 2002 (95% confidence interval [CI] 8.4%-11.5%) to 11.3% in 2009 (95% CI 9.4%-13.5%), and then declined to 7.9% in 2017 (95% CI 6.8%-9.0%). In 2017, device-associated infections accounted for 35.6% of all health care-associated infections. Methicillin-resistant In CNISP hospitals, there was a decline in the prevalence of health care-associated infection in 2017 compared with previous surveys. However, strategies to prevent infections associated with medical devices should be developed. Apart from MRSA, few infections were caused by antibiotic-resistant organisms.
Sections du résumé
BACKGROUND
BACKGROUND
Health care-associated infections are a common cause of patient morbidity and mortality. We sought to describe the trends in these infections in acute care hospitals, using data from 3 national point-prevalence surveys.
METHODS
METHODS
The Canadian Nosocomial Infection Surveillance Program (CNISP) conducted descriptive point-prevalence surveys to assess the burden of health care-associated infections on a single day in February of 2002, 2009 and 2017. Surveyed infections included urinary tract infection, pneumonia,
RESULTS
RESULTS
We surveyed 28 of 33 (response rate 84.8%) CNISP hospitals (6747 patients) in 2002, 39 of 55 (response rate 71.0%) hospitals (8902 patients) in 2009 and 47 of 66 (response rate 71.2%) hospitals (9929 patients) in 2017. The prevalence of patients with at least 1 health care-associated infection increased from 9.9% in 2002 (95% confidence interval [CI] 8.4%-11.5%) to 11.3% in 2009 (95% CI 9.4%-13.5%), and then declined to 7.9% in 2017 (95% CI 6.8%-9.0%). In 2017, device-associated infections accounted for 35.6% of all health care-associated infections. Methicillin-resistant
INTERPRETATION
CONCLUSIONS
In CNISP hospitals, there was a decline in the prevalence of health care-associated infection in 2017 compared with previous surveys. However, strategies to prevent infections associated with medical devices should be developed. Apart from MRSA, few infections were caused by antibiotic-resistant organisms.
Identifiants
pubmed: 31501180
pii: 191/36/E981
doi: 10.1503/cmaj.190361
pmc: PMC6733684
doi:
Substances chimiques
Anti-Infective Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
E981-E988Commentaires et corrections
Type : CommentIn
Informations de copyright
© 2019 Joule Inc. or its licensors.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 2015 Jan 27;313(4):398-408
pubmed: 25626036
J Prev Med Hyg. 2016 Sep;57(3):E135-E141
pubmed: 27980377
Clin Infect Dis. 2007 Sep 1;45 Suppl 2:S112-21
pubmed: 17683015
Antimicrob Resist Infect Control. 2016 May 21;5:19
pubmed: 27213039
Infect Control Hosp Epidemiol. 2017 Feb;38(2):147-153
pubmed: 27834161
Clin Infect Dis. 2017 May 15;64(suppl_2):S61-S67
pubmed: 28475790
Infect Control Hosp Epidemiol. 2014 May;35(5):455-9
pubmed: 24709713
Annu Rev Med. 2012;63:359-71
pubmed: 22017445
Infect Control Hosp Epidemiol. 2016 Apr;37(4):390-7
pubmed: 26782274
BMC Infect Dis. 2013 Dec 01;13:562
pubmed: 24289473
Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794
pubmed: 27600052
Enferm Infecc Microbiol Clin. 2012 Jun;30 Suppl 3:7-12
pubmed: 22776148
J Antimicrob Chemother. 2019 Feb 1;74(2):315-320
pubmed: 30312401
CMAJ. 2018 Jun 25;190(25):E758-E765
pubmed: 29941432
J Hosp Infect. 2005 May;60(1):40-5
pubmed: 15823655
Am J Infect Control. 2008 Jun;36(5):309-32
pubmed: 18538699
Euro Surveill. 2018 Nov;23(46):
pubmed: 30458912
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
Am J Infect Control. 2012 Aug;40(6):491-6
pubmed: 22078941
J Hosp Infect. 2010 Jul;75(3):168-72
pubmed: 20381910
Infect Control Hosp Epidemiol. 2010 Apr;31(4):348-56
pubmed: 20148693
N Engl J Med. 2018 Nov 1;379(18):1732-1744
pubmed: 30380384